(Q54484988)

English

Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

author name string

Noriko Fujita

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Takahiro Nakayama

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Noriaki Yamamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Seung Jin Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Kenzo Shimazu

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Atsushi Shimomura

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Naomi Maruyama

7

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Koji Morimoto

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Yasuhiro Tamaki

9

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Shinzaburo Noguchi

10

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

publication date

5 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

83

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

273-282

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Promoter methylation and the detection of breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Epigenomics and breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

DNA methylation as a biomarker in breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

DNA methylation markers and early recurrence in stage I lung cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

DNA methylation biomarkers for blood-based colorectal cancer screening

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Bisulfite genomic sequencing: systematic investigation of critical experimental parameters

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Histological grading of breast carcinomas: a study of interobserver agreement.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Cell-free nucleic acids as biomarkers in cancer patients

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000342083

21 January 2018

Identifiers

10.1159/000342083

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22964822

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54484988&oldid=940474938"